Fundraising Fox
Lasarrus
3 known investors
Find your way into Lasarrus
Sign up to find every way you can get introduced to Lasarrus
- Your email: who you already know at Lasarrus, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lasarrus team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.
Investors · 3
Related companies · 1
Companies working in the same space as Lasarrus.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2021 | $256K |
| National Science Foundation | Phase ISTTR | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Lasarrus do?
- Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.
- Who are Lasarrus's investors?
- Lasarrus's investors include Atlanta Technology Angels, Maryland TEDCO, TEDCO.